- Home
- TTOO vs DSS Comparison
TTOO vs DSS Comparison
Compare TTOO & DSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TTOO
- DSS
- Stock Information
- Founded
- TTOO 2006
- DSS 1984
- Country
- TTOO United States
- DSS United States
- Employees
- TTOO N/A
- DSS N/A
- Industry
- TTOO Medical/Dental Instruments
- DSS Containers/Packaging
- Sector
- TTOO Health Care
- DSS Consumer Discretionary
- Exchange
- TTOO Nasdaq
- DSS Nasdaq
- Market Cap
- TTOO 8.7M
- DSS 9.1M
- IPO Year
- TTOO 2014
- DSS N/A
- Fundamental
- Price
- TTOO $0.50
- DSS $1.06
- Analyst Decision
- TTOO Hold
- DSS
- Analyst Count
- TTOO 1
- DSS 0
- Target Price
- TTOO $5.00
- DSS N/A
- AVG Volume (30 Days)
- TTOO 1.0M
- DSS 25.7K
- Earning Date
- TTOO 11-14-2024
- DSS 11-13-2024
- Dividend Yield
- TTOO N/A
- DSS N/A
- EPS Growth
- TTOO N/A
- DSS N/A
- EPS
- TTOO N/A
- DSS N/A
- Revenue
- TTOO $7,677,000.00
- DSS $25,019,000.00
- Revenue This Year
- TTOO $50.31
- DSS N/A
- Revenue Next Year
- TTOO $117.92
- DSS N/A
- P/E Ratio
- TTOO N/A
- DSS N/A
- Revenue Growth
- TTOO N/A
- DSS N/A
- 52 Week Low
- TTOO $0.44
- DSS $1.05
- 52 Week High
- TTOO $8.38
- DSS $3.46
- Technical
- Relative Strength Index (RSI)
- TTOO 15.89
- DSS 32.07
- Support Level
- TTOO $0.51
- DSS $1.05
- Resistance Level
- TTOO $0.59
- DSS $1.18
- Average True Range (ATR)
- TTOO 0.08
- DSS 0.08
- MACD
- TTOO 0.01
- DSS -0.03
- Stochastic Oscillator
- TTOO 9.73
- DSS 2.86
About TTOO T2 Biosystems Inc.
T2 Biosystems Inc is a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes. It is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. The company's products include the T2Dx Instrument, the T2Bacteria Panel, the T2Candida Panel, the T2Resistance Panel, and the T2Biothreat Panel, and are powered by the proprietary T2 Magnetic Resonance technology.
About DSS DSS Inc.
DSS Inc is operating a business focused on Five operating segments Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. Currently operates five distinct business lines operate around the globe with primary operations in North America and Asia.